Global Real-World Evidence in Healthcare Market Research Report 2023

Publisher Name :
Date: 06-Dec-2023
No. of pages: 90
Inquire Before Buying

According to QYResearch's new survey, global Real-World Evidence in Healthcare market is projected to reach US$ 696.4 million in 2029, increasing from US$ 401 million in 2022, with the CAGR of 8.2% during the period of 2023 to 2029.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Real-World Evidence in Healthcare market with multiple angles, which provides sufficient supports to readers' strategy and decision making.

By Company

- Anthem

- IQVIA

- ICON

- PPD

- Clinigen Group

- Cognizant Technology Solutions Corporation

- Oracle

- Parexel

- PerkinElmer

- SAS Institute

- UnitedHealth Group

- Flatiron Health

Segment by Type

- Service

- Data Set

Segment by Application

- Drug Development and Approval

- Development and Approval of Medical Devices

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

The Real-World Evidence in Healthcare report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)

Chapter 2: Global market size, regional market size. Market Opportunities and Challenges

Chapter 3: Companies' Competition Patterns

Chapter 4: Product Type Analysis

Chapter 5: Product Application Analysis

Chapter 6 to 10: Country Level Value Analysis

Chapter 11: Companies' Outline

Chapter 12: Market Conclusions

Chapter 13: Research Methodology and Data Source

Global Real-World Evidence in Healthcare Market Research Report 2023

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Real-World Evidence in Healthcare Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Service
1.2.3 Data Set
1.3 Market by Application
1.3.1 Global Real-World Evidence in Healthcare Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Drug Development and Approval
1.3.3 Development and Approval of Medical Devices
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Real-World Evidence in Healthcare Market Perspective (2018-2029)
2.2 Real-World Evidence in Healthcare Growth Trends by Region
2.2.1 Global Real-World Evidence in Healthcare Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Real-World Evidence in Healthcare Historic Market Size by Region (2018-2023)
2.2.3 Real-World Evidence in Healthcare Forecasted Market Size by Region (2024-2029)
2.3 Real-World Evidence in Healthcare Market Dynamics
2.3.1 Real-World Evidence in Healthcare Industry Trends
2.3.2 Real-World Evidence in Healthcare Market Drivers
2.3.3 Real-World Evidence in Healthcare Market Challenges
2.3.4 Real-World Evidence in Healthcare Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Real-World Evidence in Healthcare Players by Revenue
3.1.1 Global Top Real-World Evidence in Healthcare Players by Revenue (2018-2023)
3.1.2 Global Real-World Evidence in Healthcare Revenue Market Share by Players (2018-2023)
3.2 Global Real-World Evidence in Healthcare Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Real-World Evidence in Healthcare Revenue
3.4 Global Real-World Evidence in Healthcare Market Concentration Ratio
3.4.1 Global Real-World Evidence in Healthcare Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Real-World Evidence in Healthcare Revenue in 2022
3.5 Real-World Evidence in Healthcare Key Players Head office and Area Served
3.6 Key Players Real-World Evidence in Healthcare Product Solution and Service
3.7 Date of Enter into Real-World Evidence in Healthcare Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Real-World Evidence in Healthcare Breakdown Data by Type
4.1 Global Real-World Evidence in Healthcare Historic Market Size by Type (2018-2023)
4.2 Global Real-World Evidence in Healthcare Forecasted Market Size by Type (2024-2029)
5 Real-World Evidence in Healthcare Breakdown Data by Application
5.1 Global Real-World Evidence in Healthcare Historic Market Size by Application (2018-2023)
5.2 Global Real-World Evidence in Healthcare Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Real-World Evidence in Healthcare Market Size (2018-2029)
6.2 North America Real-World Evidence in Healthcare Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Real-World Evidence in Healthcare Market Size by Country (2018-2023)
6.4 North America Real-World Evidence in Healthcare Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Real-World Evidence in Healthcare Market Size (2018-2029)
7.2 Europe Real-World Evidence in Healthcare Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Real-World Evidence in Healthcare Market Size by Country (2018-2023)
7.4 Europe Real-World Evidence in Healthcare Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Real-World Evidence in Healthcare Market Size (2018-2029)
8.2 Asia-Pacific Real-World Evidence in Healthcare Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Real-World Evidence in Healthcare Market Size by Region (2018-2023)
8.4 Asia-Pacific Real-World Evidence in Healthcare Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Real-World Evidence in Healthcare Market Size (2018-2029)
9.2 Latin America Real-World Evidence in Healthcare Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Real-World Evidence in Healthcare Market Size by Country (2018-2023)
9.4 Latin America Real-World Evidence in Healthcare Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Real-World Evidence in Healthcare Market Size (2018-2029)
10.2 Middle East & Africa Real-World Evidence in Healthcare Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Real-World Evidence in Healthcare Market Size by Country (2018-2023)
10.4 Middle East & Africa Real-World Evidence in Healthcare Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Anthem
11.1.1 Anthem Company Detail
11.1.2 Anthem Business Overview
11.1.3 Anthem Real-World Evidence in Healthcare Introduction
11.1.4 Anthem Revenue in Real-World Evidence in Healthcare Business (2018-2023)
11.1.5 Anthem Recent Development
11.2 IQVIA
11.2.1 IQVIA Company Detail
11.2.2 IQVIA Business Overview
11.2.3 IQVIA Real-World Evidence in Healthcare Introduction
11.2.4 IQVIA Revenue in Real-World Evidence in Healthcare Business (2018-2023)
11.2.5 IQVIA Recent Development
11.3 ICON
11.3.1 ICON Company Detail
11.3.2 ICON Business Overview
11.3.3 ICON Real-World Evidence in Healthcare Introduction
11.3.4 ICON Revenue in Real-World Evidence in Healthcare Business (2018-2023)
11.3.5 ICON Recent Development
11.4 PPD
11.4.1 PPD Company Detail
11.4.2 PPD Business Overview
11.4.3 PPD Real-World Evidence in Healthcare Introduction
11.4.4 PPD Revenue in Real-World Evidence in Healthcare Business (2018-2023)
11.4.5 PPD Recent Development
11.5 Clinigen Group
11.5.1 Clinigen Group Company Detail
11.5.2 Clinigen Group Business Overview
11.5.3 Clinigen Group Real-World Evidence in Healthcare Introduction
11.5.4 Clinigen Group Revenue in Real-World Evidence in Healthcare Business (2018-2023)
11.5.5 Clinigen Group Recent Development
11.6 Cognizant Technology Solutions Corporation
11.6.1 Cognizant Technology Solutions Corporation Company Detail
11.6.2 Cognizant Technology Solutions Corporation Business Overview
11.6.3 Cognizant Technology Solutions Corporation Real-World Evidence in Healthcare Introduction
11.6.4 Cognizant Technology Solutions Corporation Revenue in Real-World Evidence in Healthcare Business (2018-2023)
11.6.5 Cognizant Technology Solutions Corporation Recent Development
11.7 Oracle
11.7.1 Oracle Company Detail
11.7.2 Oracle Business Overview
11.7.3 Oracle Real-World Evidence in Healthcare Introduction
11.7.4 Oracle Revenue in Real-World Evidence in Healthcare Business (2018-2023)
11.7.5 Oracle Recent Development
11.8 Parexel
11.8.1 Parexel Company Detail
11.8.2 Parexel Business Overview
11.8.3 Parexel Real-World Evidence in Healthcare Introduction
11.8.4 Parexel Revenue in Real-World Evidence in Healthcare Business (2018-2023)
11.8.5 Parexel Recent Development
11.9 PerkinElmer
11.9.1 PerkinElmer Company Detail
11.9.2 PerkinElmer Business Overview
11.9.3 PerkinElmer Real-World Evidence in Healthcare Introduction
11.9.4 PerkinElmer Revenue in Real-World Evidence in Healthcare Business (2018-2023)
11.9.5 PerkinElmer Recent Development
11.10 SAS Institute
11.10.1 SAS Institute Company Detail
11.10.2 SAS Institute Business Overview
11.10.3 SAS Institute Real-World Evidence in Healthcare Introduction
11.10.4 SAS Institute Revenue in Real-World Evidence in Healthcare Business (2018-2023)
11.10.5 SAS Institute Recent Development
11.11 UnitedHealth Group
11.11.1 UnitedHealth Group Company Detail
11.11.2 UnitedHealth Group Business Overview
11.11.3 UnitedHealth Group Real-World Evidence in Healthcare Introduction
11.11.4 UnitedHealth Group Revenue in Real-World Evidence in Healthcare Business (2018-2023)
11.11.5 UnitedHealth Group Recent Development
11.12 Flatiron Health
11.12.1 Flatiron Health Company Detail
11.12.2 Flatiron Health Business Overview
11.12.3 Flatiron Health Real-World Evidence in Healthcare Introduction
11.12.4 Flatiron Health Revenue in Real-World Evidence in Healthcare Business (2018-2023)
11.12.5 Flatiron Health Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Real-World Evidence in Healthcare Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Service
Table 3. Key Players of Data Set
Table 4. Global Real-World Evidence in Healthcare Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Real-World Evidence in Healthcare Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Real-World Evidence in Healthcare Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Real-World Evidence in Healthcare Market Share by Region (2018-2023)
Table 8. Global Real-World Evidence in Healthcare Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Real-World Evidence in Healthcare Market Share by Region (2024-2029)
Table 10. Real-World Evidence in Healthcare Market Trends
Table 11. Real-World Evidence in Healthcare Market Drivers
Table 12. Real-World Evidence in Healthcare Market Challenges
Table 13. Real-World Evidence in Healthcare Market Restraints
Table 14. Global Real-World Evidence in Healthcare Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Real-World Evidence in Healthcare Market Share by Players (2018-2023)
Table 16. Global Top Real-World Evidence in Healthcare Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Real-World Evidence in Healthcare as of 2022)
Table 17. Ranking of Global Top Real-World Evidence in Healthcare Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Real-World Evidence in Healthcare Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Real-World Evidence in Healthcare Product Solution and Service
Table 21. Date of Enter into Real-World Evidence in Healthcare Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Real-World Evidence in Healthcare Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Real-World Evidence in Healthcare Revenue Market Share by Type (2018-2023)
Table 25. Global Real-World Evidence in Healthcare Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Real-World Evidence in Healthcare Revenue Market Share by Type (2024-2029)
Table 27. Global Real-World Evidence in Healthcare Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Real-World Evidence in Healthcare Revenue Market Share by Application (2018-2023)
Table 29. Global Real-World Evidence in Healthcare Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Real-World Evidence in Healthcare Revenue Market Share by Application (2024-2029)
Table 31. North America Real-World Evidence in Healthcare Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Real-World Evidence in Healthcare Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Real-World Evidence in Healthcare Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Real-World Evidence in Healthcare Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Real-World Evidence in Healthcare Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Real-World Evidence in Healthcare Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Real-World Evidence in Healthcare Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Real-World Evidence in Healthcare Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Real-World Evidence in Healthcare Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Real-World Evidence in Healthcare Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Real-World Evidence in Healthcare Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Real-World Evidence in Healthcare Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Real-World Evidence in Healthcare Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Real-World Evidence in Healthcare Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Real-World Evidence in Healthcare Market Size by Country (2024-2029) & (US$ Million)
Table 46. Anthem Company Detail
Table 47. Anthem Business Overview
Table 48. Anthem Real-World Evidence in Healthcare Product
Table 49. Anthem Revenue in Real-World Evidence in Healthcare Business (2018-2023) & (US$ Million)
Table 50. Anthem Recent Development
Table 51. IQVIA Company Detail
Table 52. IQVIA Business Overview
Table 53. IQVIA Real-World Evidence in Healthcare Product
Table 54. IQVIA Revenue in Real-World Evidence in Healthcare Business (2018-2023) & (US$ Million)
Table 55. IQVIA Recent Development
Table 56. ICON Company Detail
Table 57. ICON Business Overview
Table 58. ICON Real-World Evidence in Healthcare Product
Table 59. ICON Revenue in Real-World Evidence in Healthcare Business (2018-2023) & (US$ Million)
Table 60. ICON Recent Development
Table 61. PPD Company Detail
Table 62. PPD Business Overview
Table 63. PPD Real-World Evidence in Healthcare Product
Table 64. PPD Revenue in Real-World Evidence in Healthcare Business (2018-2023) & (US$ Million)
Table 65. PPD Recent Development
Table 66. Clinigen Group Company Detail
Table 67. Clinigen Group Business Overview
Table 68. Clinigen Group Real-World Evidence in Healthcare Product
Table 69. Clinigen Group Revenue in Real-World Evidence in Healthcare Business (2018-2023) & (US$ Million)
Table 70. Clinigen Group Recent Development
Table 71. Cognizant Technology Solutions Corporation Company Detail
Table 72. Cognizant Technology Solutions Corporation Business Overview
Table 73. Cognizant Technology Solutions Corporation Real-World Evidence in Healthcare Product
Table 74. Cognizant Technology Solutions Corporation Revenue in Real-World Evidence in Healthcare Business (2018-2023) & (US$ Million)
Table 75. Cognizant Technology Solutions Corporation Recent Development
Table 76. Oracle Company Detail
Table 77. Oracle Business Overview
Table 78. Oracle Real-World Evidence in Healthcare Product
Table 79. Oracle Revenue in Real-World Evidence in Healthcare Business (2018-2023) & (US$ Million)
Table 80. Oracle Recent Development
Table 81. Parexel Company Detail
Table 82. Parexel Business Overview
Table 83. Parexel Real-World Evidence in Healthcare Product
Table 84. Parexel Revenue in Real-World Evidence in Healthcare Business (2018-2023) & (US$ Million)
Table 85. Parexel Recent Development
Table 86. PerkinElmer Company Detail
Table 87. PerkinElmer Business Overview
Table 88. PerkinElmer Real-World Evidence in Healthcare Product
Table 89. PerkinElmer Revenue in Real-World Evidence in Healthcare Business (2018-2023) & (US$ Million)
Table 90. PerkinElmer Recent Development
Table 91. SAS Institute Company Detail
Table 92. SAS Institute Business Overview
Table 93. SAS Institute Real-World Evidence in Healthcare Product
Table 94. SAS Institute Revenue in Real-World Evidence in Healthcare Business (2018-2023) & (US$ Million)
Table 95. SAS Institute Recent Development
Table 96. UnitedHealth Group Company Detail
Table 97. UnitedHealth Group Business Overview
Table 98. UnitedHealth Group Real-World Evidence in Healthcare Product
Table 99. UnitedHealth Group Revenue in Real-World Evidence in Healthcare Business (2018-2023) & (US$ Million)
Table 100. UnitedHealth Group Recent Development
Table 101. Flatiron Health Company Detail
Table 102. Flatiron Health Business Overview
Table 103. Flatiron Health Real-World Evidence in Healthcare Product
Table 104. Flatiron Health Revenue in Real-World Evidence in Healthcare Business (2018-2023) & (US$ Million)
Table 105. Flatiron Health Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Real-World Evidence in Healthcare Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Real-World Evidence in Healthcare Market Share by Type: 2022 VS 2029
Figure 3. Service Features
Figure 4. Data Set Features
Figure 5. Global Real-World Evidence in Healthcare Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Real-World Evidence in Healthcare Market Share by Application: 2022 VS 2029
Figure 7. Drug Development and Approval Case Studies
Figure 8. Development and Approval of Medical Devices Case Studies
Figure 9. Real-World Evidence in Healthcare Report Years Considered
Figure 10. Global Real-World Evidence in Healthcare Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 11. Global Real-World Evidence in Healthcare Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Real-World Evidence in Healthcare Market Share by Region: 2022 VS 2029
Figure 13. Global Real-World Evidence in Healthcare Market Share by Players in 2022
Figure 14. Global Top Real-World Evidence in Healthcare Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Real-World Evidence in Healthcare as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by Real-World Evidence in Healthcare Revenue in 2022
Figure 16. North America Real-World Evidence in Healthcare Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 17. North America Real-World Evidence in Healthcare Market Share by Country (2018-2029)
Figure 18. United States Real-World Evidence in Healthcare Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. Canada Real-World Evidence in Healthcare Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Europe Real-World Evidence in Healthcare Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Real-World Evidence in Healthcare Market Share by Country (2018-2029)
Figure 22. Germany Real-World Evidence in Healthcare Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. France Real-World Evidence in Healthcare Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. U.K. Real-World Evidence in Healthcare Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Italy Real-World Evidence in Healthcare Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Russia Real-World Evidence in Healthcare Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Nordic Countries Real-World Evidence in Healthcare Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Asia-Pacific Real-World Evidence in Healthcare Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Real-World Evidence in Healthcare Market Share by Region (2018-2029)
Figure 30. China Real-World Evidence in Healthcare Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Japan Real-World Evidence in Healthcare Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. South Korea Real-World Evidence in Healthcare Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Southeast Asia Real-World Evidence in Healthcare Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. India Real-World Evidence in Healthcare Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Australia Real-World Evidence in Healthcare Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Latin America Real-World Evidence in Healthcare Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Real-World Evidence in Healthcare Market Share by Country (2018-2029)
Figure 38. Mexico Real-World Evidence in Healthcare Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Brazil Real-World Evidence in Healthcare Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Middle East & Africa Real-World Evidence in Healthcare Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Real-World Evidence in Healthcare Market Share by Country (2018-2029)
Figure 42. Turkey Real-World Evidence in Healthcare Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Saudi Arabia Real-World Evidence in Healthcare Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Anthem Revenue Growth Rate in Real-World Evidence in Healthcare Business (2018-2023)
Figure 45. IQVIA Revenue Growth Rate in Real-World Evidence in Healthcare Business (2018-2023)
Figure 46. ICON Revenue Growth Rate in Real-World Evidence in Healthcare Business (2018-2023)
Figure 47. PPD Revenue Growth Rate in Real-World Evidence in Healthcare Business (2018-2023)
Figure 48. Clinigen Group Revenue Growth Rate in Real-World Evidence in Healthcare Business (2018-2023)
Figure 49. Cognizant Technology Solutions Corporation Revenue Growth Rate in Real-World Evidence in Healthcare Business (2018-2023)
Figure 50. Oracle Revenue Growth Rate in Real-World Evidence in Healthcare Business (2018-2023)
Figure 51. Parexel Revenue Growth Rate in Real-World Evidence in Healthcare Business (2018-2023)
Figure 52. PerkinElmer Revenue Growth Rate in Real-World Evidence in Healthcare Business (2018-2023)
Figure 53. SAS Institute Revenue Growth Rate in Real-World Evidence in Healthcare Business (2018-2023)
Figure 54. UnitedHealth Group Revenue Growth Rate in Real-World Evidence in Healthcare Business (2018-2023)
Figure 55. Flatiron Health Revenue Growth Rate in Real-World Evidence in Healthcare Business (2018-2023)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs